ID | CAS | Name | Synonyms | Description |
---|---|---|---|---|
1 | 14875-96-8 | Heme | Heme Heme b Hematin Heme irom Protoheme Protohaem NSC 16669 Ferroheme NSC 267100 ferroheme b Protoheme IX Protoheme ix Reduced hematin Ferrous protoheme Iron protoporphyrin Ferrous protoheme IX Iron protoporphyrin ix Ferroprotoporphyrin IX Iron(II) protoporphyrin IX (protoporphyrinato)iron(II) Fe(II) Protoporphyrin IX (Hematin) FE(II) PROTOPORPHYRIN IX (HEMATIN) Iron, (dihydrogen 3,7,12,17-tetramethyl-8,13-divinyl-2,18-porphinedipropionato(2-))- iron(2+) 2,18-bis(2-carboxyethyl)-7,12-diethenyl-3,8,13,17-tetramethylporphine-21,23-diide Ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N21,N22,N23,N24)-, dihydrogen, (SP-4-2)- Ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-kappaN21,kappaN22,kappaN23,kappaN24)-, dihydrogen, (SP-4-2)- | API;Raw material;Food additive;Synthetic interme;Nutritional fortifier;Inorganic salt (mineral);Pharmaceutical raw materials;Nutritional fortifier (nutritional supplement |
2 | 152751-57-0 | SEVELAMER HCL | Sevelemar SEVELAMER HCL Sevelamer-001 Sevelamer Hydrochloride Sevelamer hydrochloride 2-Propen-1-amine polymer with (chloromethyl)oxirane hydrochloride (ChloroMethyl)oxirane polyMer with 2-Propen-1-aMine Hydrochloride 2-Propen-1-aMine Hydrochloride polyMer with 2-(ChloroMethyl)oxirane | Other APIs;Inhibitors;Heterocycles;Inorganic salt;Pharmaceuticals;Pharmaceutical intermediate;Intermediates & Fine Chemicals;Inorganic Chemical Engineering |
3 | 74863-84-6 | (2R,4R)-4-Methyl-1-[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid | 21R- GN1600 Argatroban Agaquban 21R 21R-Argatroban Argatroban Monohydrate (2r,4r)-4-methyl-1-[n-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-l-arginyl]-2-piperidinecarboxylic acid (2R,4R)-4-Methyl-1-[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid (2R,4R)-1-[N2-3-(methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-4-methyl-2-piperidinecarboxylic acid monohydrate (2R,4R)-1-[(2S)-5-guanidino-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methyl-pipecolinic acid (2R,4R)-1-{N~5~-(diaminomethylidene)-N~2~-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl]ornithyl}-4-methylpiperidine-2-carboxylic acid (2R,4R)-1-{N~5~-(diaminomethylidene)-N~2~-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl]-L-ornithyl}-4-methylpiperidine-2-carboxylic acid (2R,4R)-1-[N~5~-(diaminomethylidene)-N~2~-{[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}-L-ornithyl]-4-methylpiperidine-2-carboxylic acid (2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid (2R,4R)-1-[(2S)-5-[(AMinoiMinoMethyl)aMino]-1-oxo-2-[[[(3R)-1,2,3,4-tetrahydro-3-Methyl-8-quinolinyl]sulfonyl]aMino]pentyl]-4-Methyl-2-piperidinecarboxylic Acid (2R,4R)-1-[(2S)-5-[bis(azanyl)methylideneamino]-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid 2-Piperidinecarboxylicacid,1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[[(3R)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-,(2R,4R)- 2-Piperidinecarboxylic acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-, (2R-(1(S*(R*)),2alpha,4beta))- | Amines;Heterocycles;Chiral Reagents;Pharmaceuticals;Organic materials;Hydrocarbon compounds;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals |
4 | 330942-05-7 | Betrixaban | Betrixaban PRT 054021 Betrixaban, PRT-054021 N-(5-chloropyridin-2-yl)-2-(4-(N,N-diMethylcarbaMiMidoyl)benzaMido)-4-MethoxybenzaMide N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide N-(5-Chloro-2-pyridinyl)-2-[[4-[(diMethylaMino)iMinoMethyl]benzoyl]aMino]-5-MethoxybenzaMide 1-C-{4-[aMino(diMethylaMino)Methyl]benzene}-2-N-(5-chloropyridin-2-yl)-4-Methoxybenzene-1,2-dicarboxaMide | ;API;Aromatics;Inhibitors;Heterocycles;Raw materials;Pharmaceuticals;Mature technology;Cell biology reagents;Medical raw materials |
5 | 78218-09-4 | Dazoxiben | UK-37 AH-P719 Dazoxiben dazoxiben 74226-22-5 (Hydrochloride) 4-(2-(1-Imidazolyl)ethoxy)benzoesaeure 4-[2-(1H-lmidazol-1-yl)ethoxyl]benzoic acid BENZOIC ACID, 4-[2-(1H-IMIDAZOL-1-YL)ETHOXY]- | Drugs;Antianginal drugs;Cardiovascular and cerebrovascular drugs |
6 | 6078-17-7 | BERBAMINE DIHYDROCHLORIDE | BERBENINE BERBAMINE HCL BERBAMINE 2HCL Magnolia officinalis P.E. BERBAMINE DIHYDROCHLORIDE 6,6,7-Trimethoxy-2,2-dimethylberbaman-12-ol dihydrochloride | phytochemical;chemical reagent;pharmaceutical intermediate |
7 | 570406-98-3 | Avatrombopag | E 5501 AS 1670542 AVATROMBOPAG Avatrombopag Crenolanib Besylate Avatrombopag (AKR-501) Avatrombopag(AS1670542) Avatrombopag Base,Avatrombopag 4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]- | API;Intermediate;Standard products;Conventional products;Impurity reference substance |